首页> 外文期刊>Acta Oto-Laryngologica >Clinicopathologic study of 1176 salivary gland tumors in a Chinese population: Experience of one cancer center 1997-2007
【24h】

Clinicopathologic study of 1176 salivary gland tumors in a Chinese population: Experience of one cancer center 1997-2007

机译:中国人群1176例涎腺肿瘤的临床病理研究:一个癌症中心的经历1997-2007

获取原文
获取原文并翻译 | 示例
       

摘要

Conclusion: Chinese patients have a higher rate of lymphoepithelial carcinoma (LEC) and salivary duct carcinoma (SDC). Comprehensive use of diagnostic modalities, neck dissection, and postoperative radiation will improve the treatment results for salivary gland tumors (SGTs). Objectives: To study the clinicopathological characteristics of SGTs in a Chinese population. Methods: The records of SGT patients operated in a tertiary cancer hospital of China were retrieved. Results: From December 1997 to December 2007, 289 malignant and 887 benign SGTs were operated at Cancer Hospital, Shanghai, China. Pleomorphic adenoma and Warthin's tumor were the most common types of SGT. Mucoepidermoid carcinoma (24.6% of malignant cases) and adenoid cystic carcinoma (18.0%) were the most frequent malignant cases, followed by acinic cell carcinoma (12.1%), LEC (9.7%), and SDC (9.3%). The sensitivity and specificity of ultrasound scan, fine needle aspiration biopsy, and frozen section were 58.3 and 88.6%, 87.2 and 96.7%, 86.9 and 99.6%, respectively. Neck dissections and postoperative radiation were carried out for 48.6 and 48.0% of carcinomas, respectively. The percentage of tumors by pathologic TNM stage were 23.7% for stage I, 32.9% for stage II, 17.3% for stage III, and 26.1% for stage IV. The 5-year overall survival rate was 88.0%.
机译:结论:中国患者淋巴上皮癌(LEC)和唾液管癌(SDC)的发生率较高。诊断手段,颈部解剖和术后放射的综合使用将改善唾液腺肿瘤(SGT)的治疗效果。目的:研究中国人群中SGT的临床病理特征。方法:检索中国三级医院SGT患者的病历。结果:从1997年12月到2007年12月,在中国上海市癌症医院手术了289例恶性SGT和887例良性SGT。多形性腺瘤和沃辛瘤是最常见的SGT类型。黏液表皮样癌(占恶性病例的24.6%)和腺样囊性癌(占18.0%)是最常见的恶性肿瘤,其次是腺癌细胞(12.1%),LEC(9.7%)和SDC(9.3%)。超声扫描,细针穿刺活检和冰冻切片的敏感性和特异性分别为58.3%和88.6%,87.2%和96.7%,86.9%和99.6%。分别对48.6%和48.0%的癌症进行了颈部解剖和术后放疗。病理性TNM分期的肿瘤百分比I期为23.7%,II期为32.9%,III期为17.3%,IV期为26.1%。 5年总生存率为88.0%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号